The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Abstract
BACKGROUND: The pathophysiology of heart failure with normal ejection fraction (HFNEF) is still under discussion. Here we report the influence of cardiac inflammation on extracellular matrix (ECM) remodeling in patients with HFNEF. METHODS AND RESULTS: We investigated left ventricular systolic and diastolic function in 20 patients with HFNEF and 8 control patients by conductance catheter methods and echocardiography. Endomyocardial biopsy samples were also obtained, and ECM proteins as well as cardiac inflammatory cells were investigated. Primary human cardiac fibroblasts were outgrown from the endomyocardial biopsy samples to investigate the gene expression of ECM proteins after stimulation with transforming growth factor-β. Diastolic dysfunction was present in the HFNEF patients compared with the control patients. In endomyocardial biopsy samples from HFNEF patients, we found an accumulation of cardiac collagen, which was accompanied by a decrease in the major collagenase system (matrix metalloproteinase-1) in the heart. Moreover, a subset of inflammatory cells, which expressed the profibrotic growth factor transforming growth factor-β, could be documented in the HFNEF patients. Stimulation of primary human cardiac fibroblasts from HFNEF patients with transforming growth factor-β resulted in transdifferentiation of fibroblasts to myofibroblasts, which produced more collagen and decreased the amount of matrix metalloproteinase-1, the major collagenase in the human heart. A positive correlation between cardiac collagen, as well as the amount of inflammatory cells, and diastolic dysfunction was evident and suggests a direct influence of inflammation on fibrosis triggering diastolic dysfunction. CONCLUSIONS: Cardiac inflammation contributes to diastolic dysfunction in HFNEF by triggering the accumulation of ECM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The last two alterations are likely triggered by microvascular endothelial inflammation [70].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [70]
Citations
Cites
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P. N., Smiseth, O. A., Keulenaer, G. W. D., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,646
Self-citationOutcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,959
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,185
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,139
Souders, C. A., Bowers, S., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 1,018
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 735
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Borlaug, B. A., Melenovsky, V., Russell, S. D., Kessler, K., Pacak, K., Becker, L. C., & Kass, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.632745 · Cited by 699
Cited by
Sorted by citations
Items 401–500 of 638
Heart Failure With Preserved Ejection Fraction
Patel, A. R., & Blair, J. A. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005905 · Cited by 12
Yan, X., Wang, R., Xu, H., Tao, Z., & Ling, J. (2025) · Medical Principles and Practice · doi:10.1159/000548233 · Cited by 11
Tian, J., Li, W., Zeng, L., Yang, L. H., Du, J., Li, Y., Li, B., & Su, G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18238 · Cited by 11
Fuerlinger, A., Stockner, A., Sedej, S., & Abdellatif, M. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02566-8 · Cited by 12
Varricchi, G., Poto, R., Ferrara, A. L., Gambino, G., Marone, G., Rengo, G., Loffredo, S., & Bencivenga, L. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.10.014 · Cited by 11
Almohaimeed, G. M., Alonazi, A. S., Dayel, A. F. B., Alshammari, T. K., Alghibiwi, H. K., Alamin, M. A., Almotairi, A. R., & Al-Rasheed, N. M. (2024) · Biomedicines · doi:10.3390/biomedicines12040759 · Cited by 11
Diagnosing heart failure with preserved ejection fraction
Becher, P. M., Lindner, D., Fluschnik, N., Blankenberg, S., & Westermann, D. (2013) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.825246 · Cited by 11
Self-citationHeart Failure With Preserved Ejection Fraction
Jumean, M. F., & Konstam, M. A. (2015) · Cardiology in Review · doi:10.1097/crd.0000000000000057 · Cited by 11
Rommel, K., Lücke, C., & Lurz, P. C. (2017) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.12.033 · Cited by 11
Ihori, H., Nozawa, T., Sobajima, M., Shida, T., Fukui, Y., Fujii, N., & Inoue, H. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0779-5 · Cited by 11
Foo, Y. Y., Motakis, E., Tiang, Z., Shen, S., Lai, J. K. H., Chan, W. X., Wiputra, H., Chen, N., Chen, C. K., Winkler, C., et al. (2021) · Developmental Dynamics · doi:10.1002/dvdy.378 · Cited by 11
Fibrosis or hypertrophy: let TIMPs decide
Westermann, D., & Heymans, S. R. B. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu160 · Cited by 11
Self-citationAging and Heart Failure with Preserved Ejection Fraction
Larson, K. F., Malik, A., & Brozovich, F. V. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210035 · Cited by 12
Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis
Rohrbeck, M., Hoerr, V., Piccini, I., Greber, B., Schulte, J. S., Hübner, S.-S., Jeworutzki, E., Theiß, C., Matschke, V., Stypmann, J., et al. (2023) · Cells · doi:10.3390/cells12040550 · Cited by 10
Heart Failure in Rheumatoid Arthritis: Clinical Implications
Zambrano, A. Z., Zanatta, H. D. R., Espinoza, A. G., Bernal‐Alferes, B., Zambrano, K. Z., Salazar, J. M., & Ixcamparij-Rosales, C. H. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-024-00682-w · Cited by 11
Macrophage metabolism in inflammatory heart disease: new insights and therapeutic implications
Xiang, A., Chang, A., Zhou, J., Jin, J., Zhang, X., & Wang, Q. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1664538 · Cited by 11
Progress in heart failure treatment in Germany
Luedde, M., Spehlmann, M. E., & Frey, N. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1317-0 · Cited by 10
Tsuda, K., Kataoka, Y., Ogata, S., Nishimura, K., Nishikawa, R., Doi, T., Nakashima, T., Hosoda, H., Honda, S., Kawakami, S., et al. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-415 · Cited by 10
The Cardiomyocyte in Heart Failure with Preserved Ejection Fraction—Victim of Its Environment?
Rocca, A., van Heeswijk, R. B., Richiardi, J., Meyer, P., & Hullin, R. (2022) · Cells · doi:10.3390/cells11050867 · Cited by 10
Chen, L., Wang, W., Peng, X., Liu, L., Zhang, A., Li, X., Ma, K., & Wang, L. (2022) · Experimental Physiology · doi:10.1113/ep090243 · Cited by 10
Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
Zhbanov, K. A., Salakheeva, E. Y., Sokolova, I. Y., Анатольевна, Ж. Е., Zektser, V., Privalova, E. V., Belenkov, Y. N., & Shchendrygina, A. (2022) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2022-09-05 · Cited by 10
Shi, Y., Liu, C., Yang, C., Qiao, W., Liu, Y., Liu, S., & Dong, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1208370 · Cited by 10
Myocardial Metabolic Reprogramming in HFpEF
Zhang, Z., Sun, M., Jiang, W., Yu, L., Zhang, C., & Ma, H. (2023) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-023-10433-2 · Cited by 10
Candidate biomarkers in heart failure with reduced and preserved ejection fraction
Sinning, C., Zengin, E., Zeller, T., Schnabel, R. B., Blankenberg, S., & Westermann, D. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1068856 · Cited by 10
Self-citationMongirdienė, A., Laukaitienė, J., Skipskis, V., Kuršvietienė, L., & Liobikas, J. (2021) · Medicina · doi:10.3390/medicina57020176 · Cited by 10
Maeda, D., Sakane, K., Kanzaki, Y., Horai, R., Akamatsu, K., Tsuda, K., Ito, T., Sohmiya, K., & Hoshiga, M. (2021) · International Heart Journal · doi:10.1536/ihj.20-564 · Cited by 10
AMPK/Sirt1-mediated inflammation is positively correlated with myocardial fibrosis during ageing
Song, Y., Zhang, Y., Zhang, X., Hu, S., Wang, J., Deng, G., & Zhou, Z. (2022) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2022.2119667 · Cited by 10
Glaubitz, M., Block, S., Witte, J., Empen, K., Groß, S., Schlicht, R., Weitmann, K., Klingel, K., Kandolf, R., Hoffmann, W. U., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1188 · Cited by 10
Self-citationYe, L., Su, L., Wang, C., Loo, S., Tee, G., Tan, S. H., Khin, S. W., Ko, S., Su, B., & Cook, S. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201498 · Cited by 10
Lost in Markers? Time for phenomics and Phenomapping in Dilated Cardiomyopathy
Linthout, S. V., & Tschöpe, C. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.744 · Cited by 10
Self-citationMasuda, H., & Okada, S. (2023) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2023.1260645 · Cited by 9
Sato, M., Tsumoto, H., Toba, A., Soejima, Y., Arai, T., Harada, K., Miura, Y., & Sawabe, M. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14197 · Cited by 9
Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease
Horgan, S. J., Watson, C. J., Glezeva, N., Collier, P., Neary, R., Tea, I., Corrigan, N., Ledwidge, M. T., McDonald, K., & Baugh, J. A. (2015) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-015-9661-1 · Cited by 9
Владимировна, Л. А., Nikiforov, V. S., Станиславович, Б. С., & Terekhov, I. V. (2017) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-3-238-244 · Cited by 9
Fopiano, K. A., Jalnapurkar, S., Davila, A. C., Arora, V., & Bagi, Z. A. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x17666210831144651 · Cited by 9
Priksz, D., Lampé, N., Kov́acs, Á., Herwig, M., Bombicz, M., Varga, B., Wilisicz, T., Szilvássy, J., Pósa, A., Kiss, R., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15749 · Cited by 9
Disturbed Sleep is Not Good for the Heart: A Narrative Review
Patel, M. A., Yarlagadda, H., Upadhyay, S., Neupane, R., Qureshi, U., Raco, J., Jain, R., & Jain, R. (2022) · Current Cardiology Reviews · doi:10.2174/1573403x19666221130100141 · Cited by 9
Reactive Oxygen Species (ROS) Signaling in Cardiac Remodeling and Failure
Harvey, A., & Grieve, D. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_50 · Cited by 9
The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Psarras, S. (2024) · Biomolecules · doi:10.3390/biom14111403 · Cited by 8
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage
Netzel, B. C., Charlesworth, M. C., Johnson, K. L., French, A. J., Dispenzieri, A. A., Maleszewski, J. J., McPhail, E. D., Grogan, M. A., Redfield, M. M., Weivoda, M. M., et al. (2025) · Amyloid · doi:10.1080/13506129.2024.2448440 · Cited by 8
Zhou, Y., Yan, H., Zhu, Y., Jiang, W., & Zhang, S. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1701459 · Cited by 8
Coronary flow reserve in patients with heart failure with preserved ejection fraction
Mochula, A. V., Kopeva, K. V., Maltseva, A. N., Grakova, E. V., Gulya, M. O., Гусакова, А. М., & Zavadovsky, K. V. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-4743 · Cited by 8
Bennett, J. B., van Dinther, M., Voorter, P., Backes, W. H., Barnes, J., Barkhof, F., Captur, G., Hughes, A. D., Sudre, C. H., & Treibel, T. A. (2023) · Medicina · doi:10.3390/medicina59091596 · Cited by 9
Principles for diagnosing heart failure with preserved ejection fraction
Евгеньевич, Ш. Н., Yaroslavskaya, E. I., Криночкин, Д. В., Musikhina, N. A., Gizatulina, T. P., Enina, T. N., Petelina, T. I., Soldatova, A. M., Samoilova, E. P., Pogorelov, N. O., et al. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5448 · Cited by 8
Kang, Z., Wu, Y., Ding, Y., Zhang, Y., Cai, X., Yang, H., & Wei, J. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118419 · Cited by 8
Exploring Sirtuins: New Frontiers in Managing Heart Failure with Preserved Ejection Fraction
Lü, Y., Li, Y., Xie, Y., Bu, J., Yuan, R., & Zhang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147740 · Cited by 8
Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF)
Sala, V., Margaria, J. P., Murabito, A., Morello, F., Ghigo, A., & Hirsch, E. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0331-2 · Cited by 9
Koniari, I. C., Artopoulou, E., Velissaris, D., Kounis, N. G., & Tsigkas, G. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.05.003 · Cited by 8
Jaconiano, E., & Moreira‐Gonçalves, D. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10138-1 · Cited by 8
Itagaki, T., Motoki, H., Otagiri, K., Machida, K., Takeuchi, T., Kanai, M., Kimura, K., Higuchi, S., Minamisawa, M., Kitabayashi, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94525-6 · Cited by 8
Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF
Zhang, Y., Laer, A. O. V., Baicu, C. F., Neff, L. S., Hoffman, S., Katz, M., Zeigler, S., Zile, M. R., & Bradshaw, A. D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262479 · Cited by 8
Dehé, L., Mousa, S. A., Shaqura, M. A., Shakibaei, M., Schäfer, M., & Treskatsch, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.873169 · Cited by 8
Duni, Α., Κίτσος, Α., Bechlioulis, A., Markopoulos, G. S., Lakkas, L. S., Baxevanos, G., Mitsis, M. C., Vartholomatos, G., Naka, K. Κ., & Dounousi, E. C. (2023) · Biomedicines · doi:10.3390/biomedicines11041029 · Cited by 8
van Heerebeek, L. (2014) · SOJ Pharmacy & Pharmaceutical Sciences · doi:10.15226/2374-6866/1/2/00112 · Cited by 8
Zainal, H. A., Rolf, A., Zhou, H., Vásquez, M., Escher, F., Keller, T., Vasa‐Nicotera, M., Zeiher, A. M., Schultheiss, H., Nagel, E. C., et al. (2024) · Journal of Cardiovascular Magnetic Resonance · doi:10.1016/j.jocmr.2024.101087 · Cited by 7
Self-citationBurrage, M. K., Lewis, A. J., & Miller, J. J. J. J. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-022-07355-7 · Cited by 7
Dye, C. A., Cruz, M. D., Larsen, T. R., Nair, G. G., Marinescu, K. K., Suboc, T. M. B., Engelstein, E. D., Marsidi, J. L., Patel, P., Sharma, P. S., et al. (2023) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2023.100309 · Cited by 7
Sun, F., Yuan, L., Wang, Z., Cui, X., Lv, N., Zhang, T., Zhang, Y., & Cai, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1364758 · Cited by 7
Pankuweit, S., Lüers, C., Richter, A., Ruppert, V., Gelbrich, G., Maisch, B., & the German Competence Network Heart Failure (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12483 · Cited by 7
Narang, N., Medvedofsky, D. A., Dryer, K., Shah, S. J., Davidson, C. J., Patel, A. R., & Blair, J. E. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12170 · Cited by 7
Nona, P. J., & Russell, C. E. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.11.010 · Cited by 7
Domaszk, O., Skwarek, A., & Wojciechowska, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054903 · Cited by 7
Myocardial Basis for Heart Failure
Owen, A. A., & Spinale, F. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10005-1 · Cited by 7
Pappritz, K., Dong, F., Miteva, K., Kov́acs, Á., El-Shafeey, M. E. A., Kerim, B., O’Flynn, L., Elliman, S. J., O’Brien, T., Hamdani, N., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.632728 · Cited by 7
Self-citationEditorial: Current proceedings in magnetocardiology—past, present, future
Park, J.-W., Dischl, D., Aschbacher, K., Kranz, D. D., Rieß, J. C., Kim, S., Brachmann, J., Treskatsch, S., Heidecker, B., Landmesser, U., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1444963 · Cited by 7
Cardiometabolic Phenotype in HFpEF: Insights from Murine Models
Ogurtsova, E., Arefieva, T. I., Filatova, A. Y., Radyukhina, N. V., & Ovchinnikov, A. G. (2025) · Biomedicines · doi:10.3390/biomedicines13030744 · Cited by 6
Pathophysiologic Contributions of Visceral Adiposity to Left Ventricular Diastolic Dysfunction
Nagata, R., Obokata, M., Matsui, M., Matsui, H., Seki, Y., Igarashi, T., Sunaga, H., Kawakami, R., Harada, T., Kagami, K., et al. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10060247 · Cited by 6
Yang, M., Xu, X.-M., Zhao, X.-A., Ge, Y. Y., Qin, J., Wang, X.-Y., Dai, H., Ji, J., & Tao, S.-M. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s462895 · Cited by 7
Karuna, N., Tonry, C. L., Ledwidge, M. T., Glezeva, N., Gallagher, J., McDonald, K., & Watson, C. J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06563-7 · Cited by 6
Tian, J., Zhang, R., Weng, Y., Qin, Q., Zhang, X., Liu, A., & Lin, N. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.95875 · Cited by 6
Campos-Martins, A., Bragança, B., Correia‐de‐Sá, P., & Fontes-Sousa, A. P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.724320 · Cited by 6
Xia, W., Zhang, M., Liu, C., Wang, S., Xu, A., Xia, Z., Pang, L., & Cai, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122594 · Cited by 6
Yeh, H.-M., Lin, T., Yeh, C., Huang, H., Chang, S., Lin, J., Tsai, C., Lai, L., Huang, Y.-Y., & Chu, C.-L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188597 · Cited by 6
Tsai, Y., Chou, R., Lu, Y., Chang, C., Kuo, C., Huang, P., Chen, J., & Lin, S. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.09.017 · Cited by 6
Prat, V., Rozec, B. R., Gauthier, C., & Lauzier, B. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9645-0 · Cited by 5
Cardiomyopathies - The special entity of myocarditis and inflammatory cardiomyopathy
Escher, F., Kühl, U., Laßner, D., & Schultheiß, H. (2019) · Journal of Cardiology and Cardiovascular Medicine · doi:10.29328/journal.jccm.1001041 · Cited by 5
Self-citationImpact of coronary artery calcium on progression of diastolic dysfunction: a cohort study
Choi, K. H., Kang, D., Lee, S., Kim, D., Cho, S. W., Choi, S.-H., Park, T. K., Lee, J. M., Song, Y. B., Hahn, J., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-03956-9 · Cited by 5
RETRACTED ARTICLE: Cardiac structural remodeling in hypertensive cardiomyopathy
Sun, S.-J., Yao, J.-L., Xu, L.-B., Rui, Q., Zhang, N., Chen, M., Jiang, Y., Yang, H.-J., & Zhou, Y. (2016) · Hypertension Research · doi:10.1038/hr.2016.169 · Cited by 5
RetractedLitwin, S. E., & East, C. A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1058998 · Cited by 5
New Opportunities in Heart Failure with Preserved Ejection Fraction: From Bench to Bedside… and Back
Parra-Lucares, A., Romero-Hernández, E., Villa, E., Weitz-Muñoz, S., Vizcarra, G., Reyes, M., Vergara, D., Bustamante, S., Llancaqueo, M., V, & Toro, L. (2022) · Biomedicines · doi:10.3390/biomedicines11010070 · Cited by 5
Safabakhsh, S., Al-Shaheen, A., Swiggum, E., Mielniczuk, L. M., Tremblay‐Gravel, M., & Laksman, Z. (2022) · CJC Open · doi:10.1016/j.cjco.2022.07.012 · Cited by 6
Yang, X., Zhang, Y., Liu, Y., Lv, Q., Ye, Z., Jiang, C., & Zhang, X. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s528020 · Cited by 4
Zhang, S., Cui, Y., Chen, J., Zhou, S., Zhang, Y., Li, K., & Hou, Y. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026078 · Cited by 4
Marshall, W. R., McDonnell, T., Green, D., Sinha, S., & Kalra, P. A. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106592 · Cited by 4
Fan, G., Zhou, C., Hou, T., Li, X., Wang, L., & Wang, C. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2197312 · Cited by 4
Turning the Retrospectroscope on Heart Failure With Preserved Ejection Fraction
Paulus, W. J. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.09.022 · Cited by 4
Circulating Neuregulin-1 and Chronic Heart Failure with Preserved Ejection
Shchendrygina, A., Zhbanov, K. A., Privalova, E. V., Iusupova, A. O., Bytdaeva, A. H., Danilogorskaya, Y. A., Анатольевна, Ж. Е., Suvorov, А. Y., Zektser, V., Mnatsakanyan, M. G., et al. (2020) · Kardiologiia · doi:10.18087/cardio.2020.11.n1222 · Cited by 4
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2365 · Cited by 4
Literature Review: Pathophysiology of Heart Failure with Preserved Ejection Fraction
Ahmed, F., Kahlon, T., Mohamed, T., Ghafghazi, S., & Settles, D. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101745 · Cited by 5
Proteomic Profile of the ICAM1 p.K56M HFpEF Risk Variant
Giro, P., Filipp, M. E., Zhang, M. J., Moser, E. D., Thorp, E. B., Dalal, P., Shah, R. V., Ellinor, P. T., Cunningham, J. W., Jurgens, S. J., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.05.016 · Cited by 4
Chowdhury, N. U., Tisha, A., Sarker, J., Nath, P. D., Ahmed, N., Abdullah, S., Farooq, T., Mahmud, W., Mohib, M. M., & Sagor, M. A. T. (2018) · Journal of Angiotherapy · doi:10.25163/angiotherapy.1200032116160818 · Cited by 4
Sunaga, A., Hikoso, S., Tamaki, S., Seo, M., Yano, M., Hayashi, T., Nakagawa, A., Nakagawa, Y., Kurakami, H., Yamada, T., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13873 · Cited by 4
Myocardial performance in children with autoimmune hepatitis: Doppler tissue imaging study
Abo‐Haded, H. M., Barakat, T. S., & Hafez, M. M. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2073-9 · Cited by 4
Prevalence of Obstructive Coronary Artery Disease in Ambulatory Patients with Stable Angina Pectoris
Savvatis, D. W. K. (2015) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000387 · Cited by 4
Камышникова, Л. А., & Efremova, O. A. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-12-1070-1076 · Cited by 4
Periodontitis Accelerates Progression of Heart Failure With Preserved Ejection Fraction in Mice
Daana, S., Rokach, Y., Abedat, S., Nachman, D., Mohsen, H., Karram, S., Zandberg, Y., Tzach‐Nahman, R., Cohen, J., Amir, O., et al. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.03.002 · Cited by 3
Liu, F., Yan, L., Zhao, F., Kuai, Z., Ya-Yu, Y., Xiu-Qin, H., Si-Ao, W., Liu, Z., & Hong-Wei, P. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03775-x · Cited by 3
Liu, C., Yuan, J., Cheng, P., Yang, T., Liu, Q., Li, T., Li, C., Qu, H., & Zhou, H. (2025) · Pharmaceuticals · doi:10.3390/ph18091317 · Cited by 3
Pozzi, A., Spoladore, R., Iorio, A., Corrado, G., & D’Amario, D. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10585-0 · Cited by 4
Metadata
- Authors
- Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., Poller, W., Schultheiss, H.-P., & Tschöpe, C.
- Affiliations
- Leiden University Medical Center (NL)
- From the Department of Cardiology and Pneumology (D.W., D.L., M.K., C.Z., K.S., F.E., J.v.S., C.S., A.R., W.P., H.-P.S., C.T.), Charité, Universititäts-Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany, and Department of Cardiology (P.S.), Leiden University Medical Center, Leiden, The Netherlands.
- ORCID
- Venue
- Circulation Heart Failure
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 44-52
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2131184290
- Cited by
- 644
- References
- 55
- Citations by year
- 2026: 32 · 2025: 48 · 2024: 53 · 2023: 50 · 2022: 57 · 2021: 58 · 2020: 49 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 35 · 2015: 42 · 2014: 30 · 2013: 21 · 2012: 17
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure with preserved ejection fraction, cardiac inflammation, extracellular matrix remodeling, diastolic dysfunction, myocardial fibrosis, collagen deposition, MMP-1, TGF-beta, myofibroblasts, endomyocardial biopsy, left ventricular systolic function
- MeSH terms
- Adult, Aged, Biopsy, Cells, Cultured, Collagen, Extracellular Matrix, Female, Fibroblasts, Fibrosis, Heart, Heart Failure, Humans, Inflammation, Male, Middle Aged, Myocardium, Stroke Volume, Case-Control Studies, Transforming Growth Factor beta, Ventricular Function, Left, Extracellular Matrix Proteins, Disease Progression, Matrix Metalloproteinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review